Strategic Communications and Marketing News Bureau

How do drugs like Ozempic work for weight loss?

The weight-loss treatment landscape has been remade by a new class of injectable drugs, such as those sold under the names Ozempic and Wegovy. Patrick Sweeney is a University of Illinois Urbana-Champaign professor of molecular and integrative physiology who studies the pathways and processes in the brain that govern eating and the sense of fullness, and how those pathways are altered in conditions like obesity. He talked about the new drugs with News Bureau biomedical sciences editor Liz Ahlberg Touchstone. Video by Andy Savage.

What is the active drug in Ozempic and Wegovy? 

In Ozempic and Wegovy, the active drug is called glucagon-like peptide-1. GLP-1 is a natural compound that’s released from your gastrointestinal tract after you consume a meal. It acts to stimulate insulin secretion, which is why it helps for type 2 diabetes, but it also acts in the brain to terminate food intake or to signal satiety. These drugs take that natural form of GLP-1 and they make it much more stable and active. This clinical form is called semaglutide. When you administer semaglutide to an individual with severe obesity, it curbs their appetite, and they essentially don’t feel the need to eat as drastically. It also reduces cravings for highly palatable foods. It’s been very effective at reducing body weight.

What other effects can these drugs have on the body? 

The GLP-1 receptor is expressed throughout the brain in many different regions, so these drugs can have a variety of effects in addition to their ability to reduce feeding. In terms of side effects, oftentimes, people report nausea and vomiting. These drugs also slow gastric emptying, so they slow the food passage through the GI tract. This can sometimes lead to feelings of nausea or a condition called gastroparesis. 

Can stopping the medication cause a regain of weight? 

Unfortunately, as soon as people stop the medication, they often will regain the weight. This is true not just for drugs, but also for dieting or bariatric surgery. Regaining weight is thought to occur because there are circuits in the brain that have a sense of your body weight “set point.” Once you stop taking these drugs, feeding often increases until the body weight goes back to the previous set point that you were at before taking the drugs. The mechanisms behind this weight rebound effect are still a very active area of research.  

What should someone considering these drugs know about them? Are they for everyone looking to lose weight? 

These are life-saving drugs for individuals with type 2 diabetes. They’re really game-changing for individuals with very severe obesity and they work really well in those conditions. However, they’re not necessarily intended just for losing a few pounds. There are other strategies such as dieting and exercise, which still should be your first options.  

I want to note that there is a shortage of these drugs, and they are amazing drugs for individuals that need them. Please make sure you consult with a medical provider to talk about whether they are right for you. Be wary of online providers or companies that are trying to sell you compounds like semaglutide. Make sure that you get these compounds from medical providers whom you can trust so you know that you’re getting what it says it is.

Editor’s noteTo reach Patrick Sweeney, email sweenp@illinois.edu.  

Read Next

Engineering Civil and Environmental Engineering Professor Nishant Garg, center, is joined by fellow researchers, from left: Yujia Min, Hossein Kabir, Nishant Garg, center, Chirayu Kothari and M. Farjad Iqbal, front right. In front are examples of clay samples dissolved at different concentrations in a NaOH solution. The team invented a new test that can predict the performance of cementitious materials in mere 5 minutes. This is in contrast to the standard ASTM tests, which take up to 28 days. This new advance enables real-time quality control at production plants of emerging, sustainable materials. Photo taken at the University of Illinois Urbana-Champaign on Monday, Feb. 3, 2025. (Photo by Fred Zwicky / University of Illinois Urbana-Champaign)

Researchers develop a five-minute quality test for sustainable cement industry materials

A new test developed at the University of Illinois Urbana-Champaign can predict the performance of a new type of cementitious construction material in five minutes — a significant improvement over the current industry standard method, which takes seven or more days to complete. This development is poised to advance the use of next-generation resources called supplementary cementitious materials — or SCMs — by speeding up the quality-check process before leaving the production floor.

Library and information sciences Photo of a row of looms in a textile mill.

Illinois information sciences professor, students develop National Park Service Books to Parks websites

CHAMPAIGN, Ill. — A new National Park Service website explores the children’s book “Lyddie” as part of the Books to Parks series that connects children’s books to park service sites. Sara Schwebel, the director of the Center for Children’s Books at the University of Illinois Urbana-Champaign School of Information Sciences, worked with the National Park […]

Health and medicine Photo of Dr. Lowe standing in front of a cattle feed lot on the U. of I. campus.

What makes the bird flu virus so unusual?

The H5N1 virus attacks specific body systems in each species and behaves very differently in each depending on which body systems are involved, causing widespread death in some animals while barely affecting others, says University of Illinois Urbana-Champaign veterinary clinical medicine professor Dr. Jim Lowe. He spoke with News Bureau life sciences editor Diana Yates […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010